Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Public ClinicalTrials.gov record NCT01720069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Study identification
- NCT ID
- NCT01720069
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Vectura Limited
- Industry
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Interventions
- VR506 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Sep 30, 2013
- Completion
- Sep 30, 2013
- Last update posted
- Apr 20, 2020
2012 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vectura Clinical Trial Site 01001 | Los Angeles | California | 90025 | — |
| Vectura Clinial Trial Site 01005 | Denver | Colorado | 80206 | — |
| Vectura Clinical Trial Site 01006 | Celebration | Florida | 34747 | — |
| Vectura Clinical Trial Site 01015 | Hialeah | Florida | 33018 | — |
| Vectura Clinical Trial Site 01012 | Miami Lakes | Florida | 33016 | — |
| Vectura Clinical Trial Site 01014 | Orlando | Florida | 32806 | — |
| Vectura Clinical Trial Site 01003 | Tampa | Florida | 33613 | — |
| Vectura Clinical Trial Site 01011 | St Louis | Missouri | 63110-1093 | — |
| Vectura Clinical Trial Site 01013 | Jersey City | New Jersey | 07306 | — |
| Vectura Clinical Trial Site 01004 | The Bronx | New York | 10461 | — |
| Vectura Clinical Trial Site 01007 | El Paso | Texas | 79925 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01720069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2020 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01720069 live on ClinicalTrials.gov.